Related references
Note: Only part of the references are listed.Memories that last forever: strategies for optimizing vaccine T-cell memory
Jeffrey D. Ahlers et al.
BLOOD (2010)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
Andreas Moosmann et al.
BLOOD (2010)
Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4
P. G. Stevenson et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Follicular and Marginal Zone B Cells Fail to Cross-Present MHC Class I-Restricted Epitopes Derived from Viral Particles
Susanne A. Keller et al.
JOURNAL OF IMMUNOLOGY (2009)
Requirement of B Cells for Generating CD4+ T Cell Memory
Jason K. Whitmire et al.
JOURNAL OF IMMUNOLOGY (2009)
Herpes Simplex Virus Type 1 Production Requires a Functional ESCRT-III Complex but Is Independent of TSG101 and ALIX Expression
Tobias Pawliczek et al.
JOURNAL OF VIROLOGY (2009)
Human Cytomegalovirus Exploits ESCRT Machinery in the Process of Virion Maturation
Ritesh Tandon et al.
JOURNAL OF VIROLOGY (2009)
A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
Lesley Rees et al.
TRANSPLANTATION (2009)
Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles
Dinesh Adhikary et al.
JOURNAL OF VIROLOGY (2008)
Phase I trial of a CD8+ T-Cell peptide epitope-based vaccine for infectious mononucleosis
Suzanne L. Elliott et al.
JOURNAL OF VIROLOGY (2008)
Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
Etienne M. Sokal et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Posttransplant lymphoproliferative disorder
Matthew J. Everly et al.
ANNALS OF PHARMACOTHERAPY (2007)
Complement receptors CD21 and CD35 in humoral immunity
Ramon Roozendaal et al.
IMMUNOLOGICAL REVIEWS (2007)
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
Andrew D. Hislop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults
Michel Moutschen et al.
VACCINE (2007)
Genetic design of an optimized packaging cell line for gene vectors transducing human B cells
E Hettich et al.
GENE THERAPY (2006)
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
D Adhikary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Cellular factors required for Lassa virus budding
S Urata et al.
JOURNAL OF VIROLOGY (2006)
Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis
EL Thacker et al.
ANNALS OF NEUROLOGY (2006)
Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination
E Hellebrand et al.
GENE THERAPY (2006)
Epstein-Barr virus provides a new paradigm: A requirement for the immediate inhibition of apoptosis
M Altmann et al.
PLOS BIOLOGY (2005)
RNAs in the virion of Kaposi's sarcoma-associated herpesvirus
J Bechtel et al.
JOURNAL OF VIROLOGY (2005)
Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines
A Schattner
VACCINE (2005)
Defective infectious particles and rare packaged Genomes produced by cells carrying terminal-repeat-negative Epstein-Barr virus
R Feederle et al.
JOURNAL OF VIROLOGY (2005)
Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells
J Mautner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Proteins of purified Epstein-Barr virus
E Johannsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The protein network of HIV budding
UK von Schwedler et al.
CELL (2003)
Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2
G Lautscham et al.
JOURNAL OF VIROLOGY (2003)
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function
DG Demirov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
RNAs extracted from herpes simplex virus 1 virions: Apparent selectivity of viral but not cellular RNAs packaged in virions
MT Sciortino et al.
JOURNAL OF VIROLOGY (2001)
A listing of human tumor antigens recognized by T cells
N Renkvist et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands
A Janz et al.
JOURNAL OF VIROLOGY (2000)
A subset of viral transcripts packaged within human cytomegalovirus particles
WA Bresnahan et al.
SCIENCE (2000)
Share Paper
